Brief Communication
PatIents and methods
Sixty-four patients undergoing LDLT during January 2014 to January 2015 were enrolled, and data were collected and recorded from the date of surgery to 6 months post-surgery. All bacterial and fungal infections occurring after surgery were considered for the study, defined by isolation of infectious agent from a documented site of infection. Samples received were blood, respiratory samples, intra-abdominal fluid samples and urine. Identification and antimicrobial susceptibility testing were performed by Vitek II (Biomerieux, India Limited) in accordance with the Clinical Laboratory Standards Institute guidelines. [3] 
Results
We prospectively documented the infectious episodes in the 64 patients ( 
Analysis of the aetiological agent Bacterial infections
Klebsiella pneumoniae (KPN) was the most frequent pathogen isolated in 43 (41.74%) events, followed by Escherichia coli 20 (19.41%), Pseudomonas aeruginosa 10 (9.7%), Acinetobacter baumannii 11 (10.67%), Enterococcus spp. 7 (6.7%) and Stenotrophomonas maltophilia 5 (4.8%).
K. pneumonia was isolated from 14 respiratory, 12 intra-abdominal, 6 urinary tract and 11 bloodstream infections. E. coli was isolated from 5 respiratory, 4 intra-abdominal, 7 urinary tract and 4 bloodstream infections. P. aeruginosa was isolated from 4 respiratory, 3 intra-abdominal, 1 urinary tract and 2 surgical site infections. A. baumannii was isolated in 5 respiratory, 3 intra-abdominal and 2 bloodstream infections and 1 surgical site infection. S. maltophilia was predominantly isolated from respiratory samples. The sensitivity pattern is elucidated in Table 1 .
Enterococcus spp. was predominantly isolated in 7 (6.75) events from intra-abdominal samples (4), blood (2) and urine (1) and exhibited sensitivity to teicoplanin (78.9%), v a n c o m y c i n ( 7 8 . 9 % ) , t i g e c y c l i n e ( 1 0 0 % ) a n d linezolid (94.75%).
Fungal infections
Candida species was the predominant fungal pathogen isolated in 7 (6.7%) episodes from blood and bile samples. Candida albicans and Candida tropicalis were predominantly isolated with one episode of Candida parapsilosis from blood sample. The antifungal sensitivity is summarised in Table 2. dIscussIon Infections in LT patients are preventable and treatable if suspected at appropriate time. There was a male preponderance in our study. The incidence of post-LDLT infections was 59.5%, much higher than 48.5% reported by Chiereghin et al. with 1-year follow-up and 41% by Antunes et al. with 2-year follow-up in LT subjects. [4, 5] Souza et al. have reported an infection incidence rate of 55.3%; Vera et al. reported an incidence of 55.3%. [6, 7] The timeline study shows that majority of the infections occurred in the early post-operative period (<1 week) (30/103 [29.1%]) or in the late follow-up period (>1-6 months) (48/103 [46.6%]). Chiereghin et al. have shown higher incidence (63%) of infections within the 1 st month of surgery. [4] The late-phase insurgence in infections in our patients could be due to waning vigilance and patient care as the patient is discharged and returns to normal living by this time. All 11 patients whose death was attributable to infectious aetiology had >1 infectious episode during the 1 st post-operative week.
Early phase was marked with predominance of bloodstream infections, while in the intermediate and late phase, there was preponderance of respiratory and intra-abdominal infections. Bacterial infections were most frequent (93.2%) with predominance of Gram-negative bacteria (GNBs) accounting for 92.7% infections as compared to Gram-positive cocci in 7.3% of the bacterial infections.
KPN was the most frequently isolated GNB (41.74%). However, E. coli is the most common pathogen reported in most other studies. [5, 8] Varghese et al. have reported E. coli (20%) as the most common pathogens in both deceased donor LT and LDLT, followed by KPN (11.4%) and P. aeruginosa (5.7%). [8] Extended-spectrum beta-lactamase (ESBL) production was seen in 62% of Enterobacteriaceae isolates. Men et al. have reported 42.3% ESBL-producing pathogens from one of the largest transplant centres; other studies have also reported ESBL production in 43.3% of GNB in LT. [9] Chiereghin et al. have shown the incidence of ESBL-producing KPN as high as 68.4% and carbapenemase production in 47.4% isolates and virtually absent polymyxin resistance. [4] Carbapenemase-producing KPN (CRKP) was isolated in 65.1% which is significantly higher compared to other studies. 22.9% CRKP was reported with 71% mortality in LT recipients by Kalpoe et al. [10] In a large retrospective study of around 10 years' duration including 330 LT recipients, Barchiesi et al. reported infections in 27%, with KPN being the most commonly isolated pathogen (29%) and CRKP as high as 67%. [11] P. aeruginosa was isolated in 9.7%, of which 30% were multidrug resistant (MDR). Previous studies reported 2.8% infections, MDR P. aeruginosa 46.3% and mortality ranging from 33.3% to 38.5%. [12] Candida spp. were isolated in 6.7% cases which is comparable to a 6-year analysis of fungal infections in LTs by Zicker et al. (7%) . [13] The most common species were C. albicans (3/7) and C. tropicalis (3/7) followed by C. parapsilosis (1/7). Conditions that predispose a patient to Candida colonisation are frequent in LT recipients and can lead to overgrowth in the hepatobiliary, gastrointestinal and genitourinary tracts and facilitate fungaemia and dissemination.
We conclude that bacteria are accountable for majority of infections in LDLT, especially the MDR Gram-negative Enterobacteriaceae and Pseudomonas species with a rising trend. The infections occurring early are related to surgical procedure, medical devices or prolonged hospitalisation. The intermediate-phase infections are attributed to the hospital-acquired factors and the immunosuppressive therapy given to the patient. The late-phase surge in infections is unanticipated caused by variety of patient-related factors as it is difficult to monitor the patient after discharge. This study gives an overview of the sequential infectious complications in post-transplant patient, and the risk factors in development of these complications need to be analysed. It is essential to have in place an effective approach for infection prevention, based on the predicted infection risk, local antimicrobial resistance and surveillance of specific risk factors and infection control measures to limit and reduce infectious complications in transplant recipients.
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